BIOMAT Database Logo BIOMAT Database Logo

Immunological aspects of malignant glial tumors. 1980

E M Martin, and M H Weiss

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D007167 Immunotherapy Manipulation of the host's immune system in treatment of disease. It includes both active and passive immunization as well as immunosuppressive therapy to prevent graft rejection. Immunotherapies
D009423 Nervous System Neoplasms Benign and malignant neoplastic processes arising from or involving components of the central, peripheral, and autonomic nervous systems, cranial nerves, and meninges. Included in this category are primary and metastatic nervous system neoplasms. Neoplasms, Nervous System,Nervous System Tumors,Tumors of the Nervous System,Neoplasm, Nervous System,Nervous System Neoplasm,Nervous System Tumor,Tumor, Nervous System,Tumors, Nervous System
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000951 Antigens, Neoplasm Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin. Neoplasm Antigens,Tumor Antigen,Tumor Antigens,Antigen, Tumor,Antigens, Tumor

Related Publications

E M Martin, and M H Weiss
Immunological aspects of intrinsic glial tumors.
July 1981, Journal of neurosurgery,
E M Martin, and M H Weiss
Immunological aspects of benign and malignant tumors of the prostate.
January 1985, Contributions to gynecology and obstetrics,
E M Martin, and M H Weiss
Immunological aspects of malignant disease.
June 1967, Lancet (London, England),
E M Martin, and M H Weiss
[Immunological aspects of malignant neoplasms].
August 1971, Die Medizinische Welt,
E M Martin, and M H Weiss
Immunological aspects of malignant disease.
August 1971, The Medical journal of Australia,
E M Martin, and M H Weiss
[Immunological aspects of malignant lymphomas].
February 1978, Recenti progressi in medicina,
E M Martin, and M H Weiss
Immunological Aspects of Malignant Gliomas.
July 2016, The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques,
E M Martin, and M H Weiss
Molecular pathogenesis of malignant glial tumors.
January 2011, Toxicologic pathology,
E M Martin, and M H Weiss
[Immunological aspects of trophoblastic tumors].
April 1976, Ginekologia polska,
E M Martin, and M H Weiss
[Immunological aspects in malignant melanoma].
January 1972, Archiv fur dermatologische Forschung,
Copied contents to your clipboard!